Literature DB >> 21598004

Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer.

Kathrin Bauer1, Sara Michel, Miriam Reuschenbach, Nina Nelius, Magnus von Knebel Doeberitz, Matthias Kloor.   

Abstract

High level microsatellite instability (MSI-H) is a hallmark of Lynch syndrome-associated colorectal cancer (CRC). MSI-H CRC express immunogenic tumour antigens as a consequence of DNA mismatch repair deficiency-induced frameshift mutations. Consequently, frameshift antigen-specific immune responses are commonly observed in patients with Lynch syndrome-associated MSI-H CRC. Dendritic cells (DC) and macrophages play a crucial role in the induction and modulation of immune responses. We here analysed DC and macrophage infiltration in MSI-H and microsatellite-stable CRC. Sixty-nine CRC (MSI-H, n = 33; microsatellite-stable, n = 36) were examined for the density of tumour-infiltrating DC, Foxp3-positive regulatory T cells, and CD163-positive macrophages. In MSI-H lesions, S100-positive and CD163-positive cell counts were significantly higher compared to microsatellite-stable lesions (S100: epithelium P = 0.018, stroma P = 0.042; CD163: epithelium P < 0.001, stroma P = 0.046). Additionally, numbers of CD208-positive mature DC were significantly elevated in the epithelial compartment of MSI-H CRC (P = 0.027). High numbers of tumour-infiltrating Foxp3-positive T cells were detected in tumours showing a low proportion of CD208-positive, mature DC among the total number of S100-positive cells. Our study demonstrates that infiltration with DC, mature DC, and macrophages is elevated in MSI-H compared to microsatellite-stable CRC. The positive correlation of Foxp3-positive Treg cell density with a low proportion of mature DC suggests that impaired DC maturation may contribute to local immune evasion in CRC. Our results demonstrate that DC and macrophages in the tumour environment likely play an important role in the induction of antigen-specific immune responses in Lynch syndrome. Moreover, impaired DC maturation might contribute to local immune evasion in CRC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21598004     DOI: 10.1007/s10689-011-9449-7

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  46 in total

Review 1.  Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications.

Authors:  Sergio Rutella; Roberto M Lemoli
Journal:  Immunol Lett       Date:  2004-06-15       Impact factor: 3.685

Review 2.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 3.  Foxp3+ regulatory T cells: differentiation, specification, subphenotypes.

Authors:  Markus Feuerer; Jonathan A Hill; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2009-07       Impact factor: 25.606

4.  Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163).

Authors:  P Högger; J Dreier; A Droste; F Buck; C Sorg
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

5.  High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.

Authors:  R Dolcetti; A Viel; C Doglioni; A Russo; M Guidoboni; E Capozzi; N Vecchiato; E Macrì; M Fornasarig; M Boiocchi
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

6.  Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma-carcinoma sequence.

Authors:  Guanglin Cui; Aping Yuan; Rasmus Goll; Trine Olsen; Anne Husebekk; Barthold Vonen; Jon Florholmen
Journal:  Cancer Immunol Immunother       Date:  2007-06-20       Impact factor: 6.968

7.  Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer.

Authors:  Hiroyuki Suzuki; Nobuhito Chikazawa; Takehiko Tasaka; Junji Wada; Akio Yamasaki; Yoshiki Kitaura; Masae Sozaki; Masao Tanaka; Hideya Onishi; Takashi Morisaki; Mitsuo Katano
Journal:  Cancer Immunol Immunother       Date:  2009-11-12       Impact factor: 6.968

8.  Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells.

Authors:  A R Dadabayev; M H Sandel; A G Menon; H Morreau; C J M Melief; R Offringa; S H van der Burg; C Janssen-van Rhijn; N G Ensink; R A E M Tollenaar; C J H van de Velde; P J K Kuppen
Journal:  Cancer Immunol Immunother       Date:  2004-06-17       Impact factor: 6.968

9.  Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study.

Authors:  Mark A Jenkins; Shinichi Hayashi; Anne-Marie O'Shea; Lawrence J Burgart; Tom C Smyrk; David Shimizu; Paul M Waring; Andrew R Ruszkiewicz; Aaron F Pollett; Mark Redston; Melissa A Barker; John A Baron; Graham R Casey; James G Dowty; Graham G Giles; Paul Limburg; Polly Newcomb; Joanne P Young; Michael D Walsh; Stephen N Thibodeau; Noralane M Lindor; Loïc Lemarchand; Steven Gallinger; Robert W Haile; John D Potter; John L Hopper; Jeremy R Jass
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

10.  Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases.

Authors:  A Buckowitz; H-P Knaebel; A Benner; H Bläker; J Gebert; P Kienle; M von Knebel Doeberitz; M Kloor
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

View more
  29 in total

Review 1.  Immunological battlefield in gastric cancer and role of immunotherapies.

Authors:  Minyu Wang; Rita A Busuttil; Sharon Pattison; Paul J Neeson; Alex Boussioutas
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

2.  ATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment.

Authors:  Chi-Fen Chen; Rolando Ruiz-Vega; Priya Vasudeva; Francisco Espitia; Tatiana B Krasieva; Sebastien de Feraudy; Bruce J Tromberg; Sharon Huang; Chad P Garner; Jie Wu; Dave S Hoon; Anand K Ganesan
Journal:  Cell Rep       Date:  2017-03-07       Impact factor: 9.423

Review 3.  Genotypic and phenotypic signatures to predict immune checkpoint blockade therapy response in patients with colorectal cancer.

Authors:  Xianda Zhao; Audre May; Emil Lou; Subbaya Subramanian
Journal:  Transl Res       Date:  2018-02-12       Impact factor: 7.012

Review 4.  Phenotypic and genotypic heterogeneity of Lynch syndrome: a complex diagnostic challenge.

Authors:  Henry T Lynch; Stephen Lanspa; Trudy Shaw; Murray Joseph Casey; Marc Rendell; Mark Stacey; Theresa Townley; Carrie Snyder; Megan Hitchins; Joan Bailey-Wilson
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

5.  Lynch syndrome: new tales from the crypt.

Authors:  C Richard Boland
Journal:  Lancet Oncol       Date:  2012-05-01       Impact factor: 41.316

6.  Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis.

Authors:  Sarah M Lo; Murim Choi; Jun Liu; Dhanpat Jain; Rolf G Boot; Wouter W Kallemeijn; Johannes M F G Aerts; Farzana Pashankar; Gary M Kupfer; Shrikant Mane; Richard P Lifton; Pramod K Mistry
Journal:  Blood       Date:  2012-04-04       Impact factor: 22.113

Review 7.  Towards a vaccine to prevent cancer in Lynch syndrome patients.

Authors:  Magnus von Knebel Doeberitz; Matthias Kloor
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

8.  Recent discoveries in the molecular genetics of Lynch syndrome.

Authors:  C Richard Boland
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

9.  Immunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives.

Authors:  Timothy J Zumwalt; Ajay Goel
Journal:  Curr Colorectal Cancer Rep       Date:  2015-06-29

Review 10.  Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers.

Authors:  Vito Amodio; Gianluca Mauri; Nicole M Reilly; Andrea Sartore-Bianchi; Salvatore Siena; Alberto Bardelli; Giovanni Germano
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.